At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 140 enrolled
Drug / intervention
Propofol +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety Profiles of Sedation With Propofol Combined With Intravenous Midazolam and Meperidine Versus Intravenous Midazolam and Meperidine for Ambulatory Endoscopic Retrograde-cholangiopancreatography(ERCP).
In Brief
A Phase 4 clinical trial evaluating Propofol, Midazolam, and 1 other intervention for Disorders of Gallbladder, Biliary Tract and Pancrease. Completed, enrolled 140 participants across 1 site.
Detailed Summary
The purpose of this study is to compare efficacy and safety of combination of propofol and midazolam with meperidine versus midazolam and meperidine for ambulatory ERCP
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesThailand
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
First PostedOct 2012
Primary CompletionNov 2012
TodayJul 2026
First PostedOct 18, 2012
Enrollment StartJun 1, 2010
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 13.7 years ago
Interventions
Propofoldrug
Propofol is the sedative drug used as an additional sedation to one of the study arm.
Midazolamdrug
Midazolam is one of the two conventional sedative drugs included in both arms.
Meperidinedrug
Meperidine is one of the two conventional sedative drugs included in both arms.